BioNeutra Global Corporation

BGACF · OTC
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Operating Activities
Net Income-$412-$757-$833$1,392
Dep. & Amort.-$277$209$221$304
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$534$628-$602-$1,210
Other Non-Cash$188$194$759$1,179
Operating Cash Flow$33$274-$1,213-$292
Investing Activities
PP&E Inv.-$13-$54$0-$5
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$13-$54$0-$5
Financing Activities
Debt Repay.-$100-$91-$95$1,028
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$125-$67-$198-$499
Financing Cash Flow-$225-$158-$95$1,028
Forex Effect$646-$176-$112$367
Net Chg. in Cash$441-$115-$1,420$1,099
Supplemental Information
Beg. Cash$354$469$1,889$790
End Cash$795$354$469$1,889
Free Cash Flow$20$219-$1,213-$296